These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 11514172)

  • 41. Synthesis and evaluation of indenopyrazoles as cyclin-dependent kinase inhibitors. 3. Structure activity relationships at C3(1,2).
    Yue EW; Higley CA; DiMeo SV; Carini DJ; Nugiel DA; Benware C; Benfield PA; Burton CR; Cox S; Grafstrom RH; Sharp DM; Sisk LM; Boylan JF; Muckelbauer JK; Smallwood AM; Chen H; Chang CH; Seitz SP; Trainor GL
    J Med Chem; 2002 Nov; 45(24):5233-48. PubMed ID: 12431051
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The nuclear protein p34SEI-1 regulates the kinase activity of cyclin-dependent kinase 4 in a concentration-dependent manner.
    Li J; Melvin WS; Tsai MD; Muscarella P
    Biochemistry; 2004 Apr; 43(14):4394-9. PubMed ID: 15065884
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Roscovitine, olomoucine, purvalanol: inducers of apoptosis in maturing cerebellar granule neurons.
    Monaco EA; Beaman-Hall CM; Mathur A; Vallano ML
    Biochem Pharmacol; 2004 May; 67(10):1947-64. PubMed ID: 15130771
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cyclin D-dependent kinases, INK4 inhibitors and cancer.
    Ortega S; Malumbres M; Barbacid M
    Biochim Biophys Acta; 2002 Mar; 1602(1):73-87. PubMed ID: 11960696
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Novel Cdk inhibitors restore TGF-beta sensitivity in cdk4 overexpressing epithelial cells.
    Soni R; Fretz H; Muller L; Schoepfer J; Chaudhuri B
    Biochem Biophys Res Commun; 2000 Jun; 272(3):794-800. PubMed ID: 10860833
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Solution structure of p21(Waf1/Cip1/Sdi1) C-terminal domain bound to Cdk4.
    Sung YH; Shin J; Shin J; Lee W
    J Biomol Struct Dyn; 2001 Dec; 19(3):419-27. PubMed ID: 11790141
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Repression of the CDK activator Cdc25A and cell-cycle arrest by cytokine TGF-beta in cells lacking the CDK inhibitor p15.
    Iavarone A; Massagué J
    Nature; 1997 May; 387(6631):417-22. PubMed ID: 9163429
    [TBL] [Abstract][Full Text] [Related]  

  • 48. 5-Arylamino-2-methyl-4,7-dioxobenzothiazoles as inhibitors of cyclin-dependent kinase 4 and cytotoxic agents.
    Ryu CK; Kang HY; Lee SK; Nam KA; Hong CY; Ko WG; Lee BH
    Bioorg Med Chem Lett; 2000 Mar; 10(5):461-4. PubMed ID: 10743948
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Thio- and oxoflavopiridols, cyclin-dependent kinase 1-selective inhibitors: synthesis and biological effects.
    Kim KS; Sack JS; Tokarski JS; Qian L; Chao ST; Leith L; Kelly YF; Misra RN; Hunt JT; Kimball SD; Humphreys WG; Wautlet BS; Mulheron JG; Webster KR
    J Med Chem; 2000 Nov; 43(22):4126-34. PubMed ID: 11063609
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Molecular mechanisms underlying interferon-alpha-induced G0/G1 arrest: CKI-mediated regulation of G1 Cdk-complexes and activation of pocket proteins.
    Sangfelt O; Erickson S; Castro J; Heiden T; Gustafsson A; Einhorn S; Grandér D
    Oncogene; 1999 May; 18(18):2798-810. PubMed ID: 10362250
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Characterization of novel inhibitors of cyclin-dependent kinases.
    Kent LL; Hull-Campbell NE; Lau T; Wu JC; Thompson SA; Nori M
    Biochem Biophys Res Commun; 1999 Jul; 260(3):768-74. PubMed ID: 10403840
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pyrido[2,3-d]pyrimidin-7-ones as specific inhibitors of cyclin-dependent kinase 4.
    VanderWel SN; Harvey PJ; McNamara DJ; Repine JT; Keller PR; Quin J; Booth RJ; Elliott WL; Dobrusin EM; Fry DW; Toogood PL
    J Med Chem; 2005 Apr; 48(7):2371-87. PubMed ID: 15801830
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Estrogen induces early and timed activation of cyclin-dependent kinases 4, 5, and 6 and increases cyclin messenger ribonucleic acid expression in rat uterus.
    Altucci L; Addeo R; Cicatiello L; Germano D; Pacilio C; Battista T; Cancemi M; Petrizzi VB; Bresciani F; Weisz A
    Endocrinology; 1997 Mar; 138(3):978-84. PubMed ID: 9048598
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cyclin-dependent kinase inhibitors.
    Fischer PM; Endicott J; Meijer L
    Prog Cell Cycle Res; 2003; 5():235-48. PubMed ID: 14593718
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Structure of the cyclin-dependent kinase inhibitor p19Ink4d.
    Luh FY; Archer SJ; Domaille PJ; Smith BO; Owen D; Brotherton DH; Raine AR; Xu X; Brizuela L; Brenner SL; Laue ED
    Nature; 1997 Oct; 389(6654):999-1003. PubMed ID: 9353127
    [TBL] [Abstract][Full Text] [Related]  

  • 56. An NF-kappaB-specific inhibitor, IkappaBalpha, binds to and inhibits cyclin-dependent kinase 4.
    Li J; Joo SH; Tsai MD
    Biochemistry; 2003 Nov; 42(46):13476-83. PubMed ID: 14621993
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Discovery of [4-Amino-2-(1-methanesulfonylpiperidin-4-ylamino)pyrimidin-5-yl](2,3-difluoro-6- methoxyphenyl)methanone (R547), a potent and selective cyclin-dependent kinase inhibitor with significant in vivo antitumor activity.
    Chu XJ; DePinto W; Bartkovitz D; So SS; Vu BT; Packman K; Lukacs C; Ding Q; Jiang N; Wang K; Goelzer P; Yin X; Smith MA; Higgins BX; Chen Y; Xiang Q; Moliterni J; Kaplan G; Graves B; Lovey A; Fotouhi N
    J Med Chem; 2006 Nov; 49(22):6549-60. PubMed ID: 17064073
    [TBL] [Abstract][Full Text] [Related]  

  • 58. New fascaplysin-based CDK4-specific inhibitors: design, synthesis and biological activity.
    Aubry C; Jenkins PR; Mahale S; Chaudhuri B; Maréchal JD; Sutcliffe MJ
    Chem Commun (Camb); 2004 Aug; (15):1696-7. PubMed ID: 15278142
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Induction of growth arrest and cell death by overexpression of the cyclin-Cdk inhibitor p21 in hamster BHK21 cells.
    Sekiguchi T; Hunter T
    Oncogene; 1998 Jan; 16(3):369-80. PubMed ID: 9467962
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Regulation of cyclin D-dependent kinase activity in rat liver regeneration.
    Kato A; Ota S; Bamba H; Wong RM; Ohmura E; Imai Y; Matsuzaki F
    Biochem Biophys Res Commun; 1998 Apr; 245(1):70-4. PubMed ID: 9535785
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.